AFRM vs RYTM · P/E 590, rev $3.22B vs rev $130.1M
Affirm Holdings Inc (AFRM) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the AFRM and RYTM stock pages for the full models.
Not investment advice.